Related references
Note: Only part of the references are listed.Reduced-Intensity Allogeneic Transplantation Using Alemtuzumab from HLA-Matched Related, Unrelated, or Haploidentical Related Donors for Patients with Hematologic Malignancies
Junya Kanda et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT
A. Marek et al.
BONE MARROW TRANSPLANTATION (2014)
Haploidentical related-donor hematopoietic cell transplantation in children using megadoses of CliniMACs-selected CD34+ cells and a fixed CD3+ dose
C. C. Dvorak et al.
BONE MARROW TRANSPLANTATION (2013)
Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy
C. R. Y. Cruz et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
The immunogenicity of virus-derived 2A sequences in immunocompetent individuals
C. Arber et al.
GENE THERAPY (2013)
T-cell reconstitution after allogeneic stem cell transplantation: assessment by measurement of the sjTREC/βTREC ratio and thymic naive T cells
Simone Ringhoffer et al.
HAEMATOLOGICA (2013)
EFFICACY AND SAFETY OF QUIZARTINIB (AC220) IN PATIENTS AGE ≥60 YEARS WITH FLT3-ITD-POSITIVE RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
H. Doehner et al.
HAEMATOLOGICA (2013)
Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant
Karen K. Ballen et al.
BLOOD (2012)
T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation
Luca Vago et al.
BLOOD (2012)
Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation
Chen-Hua Yan et al.
BLOOD (2012)
Haploidentical stem cell transplantation for children with high-risk leukemia
Julia Palma et al.
PEDIATRIC BLOOD & CANCER (2012)
Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never again
A. Toubert et al.
TISSUE ANTIGENS (2012)
Thymic T-cell development in allogeneic stem cell transplantation
Werner Krenger et al.
BLOOD (2011)
Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age
Emilie Castermans et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Defining the Intensity of Conditioning Regimens: Working Definitions
Andrea Bacigalupo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation
Emmanuel Clave et al.
BLOOD (2009)
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation
Ann M. Leen et al.
BLOOD (2009)
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study
Fabio Ciceri et al.
LANCET ONCOLOGY (2009)
Comparable Outcome of Alternative Donor and Matched Sibling Donor Hematopoietic Stem Cell Transplant for Children with Acute Lymphoblastic Leukemia in First or Second Remission Using Alemtuzumab in a Myeloablative Conditioning Regimen
Alana A. Kennedy-Nasser et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation
Fabio Ciceri et al.
BLOOD (2008)
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes
Concetta Quintarelli et al.
BLOOD (2007)
Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation
Siok-Keen Tey et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: Fast engraftment and low toxicity
Wolfgang A. Bethge et al.
EXPERIMENTAL HEMATOLOGY (2006)
Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation
Persis J. Amrolia et al.
BLOOD (2006)
An inducible caspase 9 safety switch for T-cell therapy
KC Straathof et al.
BLOOD (2005)
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse
F Aversa et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients
XH Chen et al.
BLOOD (2005)
Central memory and effector memory T cell subsets: Function, generation, and maintenance
F Sallusto et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Selective depletion of donor alloreactive T cells without loss of antiviral or antileukernic responses
PJ Amrolia et al.
BLOOD (2003)
Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation
BR Dey et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation:: a phase 1/2 study
I André-Schmutz et al.
LANCET (2002)
Immune reconstitution after haematopoietic cell transplantation in children:: immunophenotype analysis with regard to factors affecting the speed of recovery
K Kalwak et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903, in healthy volunteers
JD Iuliucci et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors
M Eyrich et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Megadose transplantation of purified peripheral blood CD34+progenitor cells from HLA-mismatched parental donors in children
R Handgretinger et al.
BONE MARROW TRANSPLANTATION (2001)
Share Paper
